# Hvsen Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hvsen-biotech

- Industry: Agribusiness
- Headquarters: Wuhan, China
- Website: www.whhsyy.com
- Total disclosed funding: $19M
- Latest round: Series D (Dec 26, 2018)
- Investors on record: 3

## About

Established in 2002 and headquartered in Wuhan, China, Wuhan Hvsen Biotech Co., Ltd. has developed into a key enterprise within China’s animal health industry. The company integrates R&D, manufacturing, and sales across its veterinary pharmaceutical operations. The company has expanded its operations with facilities in Wuchang, Dongxihu and Baiquan districts.

The company's core products include veterinary drug formulations, active pharmaceutical ingredients, and traditional Chinese veterinary medicine extracts used for disease prevention and treatment in livestock and companion animals. 

The company generates revenue primarily through the domestic and international sale of veterinary pharmaceuticals and related products.

## Funding rounds

- Series D, Dec 26, 2018, $7.3M — South China Venture Capital, First Capital
- Series C, Nov 28, 2013, $6M — Shenzhen Capital Real Estate Fund
- Series A, Dec 1, 2010, $6M — Shenzhen Capital Real Estate Fund

## Investors

- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series A, Series C
- South China Venture Capital (https://capitalatlas.ai/funds/south-china-venture-capital) — Series D
- First Capital (https://capitalatlas.ai/funds/first-capital) — Series D